Routine newborn screening could catch cytomegalovirus infections before problems appear

by Hebrew University of Jerusalem

edited by Gaby Clark, reviewed by Robert Egan

Gaby Clark

Scientific Editor

Meet our editorial team
Behind our editorial process

Robert Egan

Senior Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source

A newborn can look perfectly healthy, pass a hearing test and still carry an infection that may affect hearing or development later in childhood. That is the challenge posed by congenital cytomegalovirus, or cCMV, one of the most common infections passed from a mother to a baby during pregnancy. Most babies born with the virus show no obvious signs at birth, making it difficult to know which children may need closer monitoring.

Now, a large three-year study led by Dana Wolf and Smadar Eventov Friedman of the Hadassah Medical Center, and Moran Yassour of the Hebrew University of Jerusalem, suggests that routinely screening all newborns could uncover many of these otherwise invisible cases. Wolf is also affiliated with the Hebrew University of Jerusalem. The study was published in The Lancet Infectious Diseases.

The researchers reported on the screening of 48,556 newborns, representing nearly 95% of babies born at Hadassah Medical Center's two hospitals in Jerusalem between April 2022 and March 2025. They identified 176 infants with congenital CMV, or about 3.6 cases for every 1,000 babies screened.

The most striking finding was how many would otherwise have gone undetected.

Under the more common targeted approach, babies are generally tested when there is a reason to suspect CMV, such as a failed hearing test, signs of congenital CMV illness or a known maternal infection during pregnancy. But 100 of the 176 babies with cCMV, or 57%, would not have qualified for this type of screening.

In other words, more than half appeared healthy enough that there would have been no obvious reason to test them.

That matters because congenital CMV is a leading cause of nongenetic hearing loss and can also affect neurological development. Some complications may emerge only later. Early diagnosis can allow doctors to monitor hearing and development and, in certain cases, begin antiviral treatment during a time-sensitive window.

Among the 100 babies who would have been missed without universal screening, eight were later found to have moderate to severe signs of cCMV, while three had hearing loss despite appearing otherwise asymptomatic. Eleven ultimately received antiviral treatment.

Making universal screening practical

Testing every newborn individually could place a significant burden on hospital laboratories. The researchers used a pooled saliva-testing system based on a method the team originally developed to increase the number of COVID-19 PCR tests that laboratories could process during the pandemic. They have now adapted that strategy for a different, ongoing public health challenge: screening newborns for congenital CMV.

Saliva samples from several babies were combined and tested together using PCR. If a pooled sample tested positive, the babies were investigated further, with positive saliva results confirmed through urine testing.

This approach reduced the number of laboratory tests required by 83% compared with testing each sample separately, while maintaining high detection sensitivity and allowing nearly 95% of newborns to be screened.

Passing the hearing test does not rule out CMV

Newborn hearing tests remain important, but the findings show that they cannot catch every baby affected by CMV.

Some babies discovered only through universal screening had sensorineural hearing loss despite passing the routine newborn hearing test. At one year, a small proportion of babies detected only through universal screening had permanent hearing or balance-related problems.

There was also reassuring news. Among babies found only through universal screening who were completely asymptomatic after their initial medical evaluation, those with one-year follow-up had normal hearing and development. The researchers cautioned, however, that some effects can appear later, making longer-term follow-up important.

Previous CMV infection does not eliminate the risk

The study also found that congenital CMV was not limited to mothers experiencing their first infection.

Among 158 cases where the mother's infection history was known, 53% followed a non-primary infection, meaning the mother had previously been exposed to CMV, while 47% followed a first infection. Babies in both groups had similar rates of significant symptoms, hearing loss and complications at one year.

Should every newborn be screened?

The researchers say their findings strengthen the case for universal newborn CMV screening and show that pooled saliva testing can make large-scale screening more practical.

Still, questions remain. The study was conducted at two hospitals, and researchers noted that screening can sometimes uncover findings whose medical significance is unclear. The study also did not directly assess the overall cost-benefit of universal screening, which the authors say should be examined before widespread implementation.

The central problem, however, is simple: Many babies with congenital CMV look completely healthy at birth.

Without routine screening, some may be identified only after hearing or developmental problems begin to appear. Universal screening could give doctors and families the chance to find those children earlier.

Publication details

Smadar Eventov Friedman et al, Lessons derived from a 3-year congenital cytomegalovirus screening programme in Israel: a prospective population-based cohort study, The Lancet Infectious Diseases (2026). DOI: 10.1016/s1473-3099(25)00620-6

Journal information: Lancet Infectious Diseases

Key medical concepts

Hearing Loss, Sensorineural

Clinical categories

PediatricsInfectious diseasesChildren's healthCommon illnesses & PreventionLaboratory medicine Provided by Hebrew University of Jerusalem Who's behind this story?

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Routine newborn screening could catch cytomegalovirus infections before problems appear (2026, September 27) retrieved 27 September 2026 from https://medicalxpress.com/news/2026-09-routine-newborn-screening-cytomegalovirus-infections.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.